• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
TONG Tiantian,YUN Xuan,CHENG Yiqiang,DENG Zixin,ZHU Dongqing.Biosynthesis of romidepsin-class anticancer drugs[J].Journal Of Pharmaceutical Research,2017,36(12):683-688,699[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3156times   Download 3215次 QR Code for this article
Scan with your phone!
罗米地辛类抗癌药物的生物合成
童甜甜1,云轩1,程义强1,2,邓子新1,朱冬青1
Font:Larger+|Default|Smaller-
(1.武汉大学药学院,组合生物合成与新药发现教育部重点实验室,湖北 武汉 430071;2.北德克萨斯大学健康科学中心大学药学UNT系统学院,美国 德克萨斯 76107)
摘要:
罗米地辛(又称FK228)是紫色色杆菌中非核糖体肽合酶(NRPS)和I型聚酮合酶(PKS)催化合成的一种缩酚酸肽类天然产物,具有组蛋白脱乙酰基酶抑制剂活性,现被用于皮肤T细胞淋巴瘤和外周T细胞淋巴瘤的临床治疗。我们对已发现的罗米地辛类天然产物的化学结构,生物合成基因簇和生物合成途径的研究现状进行了总结,在此基础上初步探讨了通过基因组挖掘和组合生物合成等生物学手段获取新的罗米地辛类天然产物的可能性。
关键词:  罗米地辛  组蛋白脱乙酰基酶抑制剂  生物合成基因簇  基因组挖掘  组合生物合成
DOI:10.13506/j.cnki.jpr.2017.12.001
基金项目:国家自然科学基金项目(No.81373305、31401057)
Biosynthesis of romidepsin-class anticancer drugs
TONG Tiantian,YUN Xuan1,CHENG Yiqiang1,2,DENG Zixin1,ZHU Dongqing1
(1.Key Laboratory of Combinatorial Biosynthesis and Drug Discovery,Ministry of Education, School of Pharmaceutical Sciences,WuhanUniversity,Wuhan 430071,China;2.UNT System College of Pharmacy,University of North Texas Health Science Center,Texas 76107,USA)
Abstract:
Romidepsin (also known as FK228),a depsipeptide natural product biosynthesized by nonribosomal peptide synthases (NRPSs) and type I polyketide synthases (PKSs) in Chromobacteriumviolaceum, was identified as a potent histone deacetylase inhibitor (HDACi) and approved by the US FDA for the treatments of cutaneous T-cell lymphoma and peripheral T-cell lymphoma.In this paper,the progress regarding romidepsin-classnatural products identified in chemical structures,biosynthetic gene clusters and biosynthetic pathways werereviewed.The possibility of obtaining new romidepsin analogues via genome mining and combinatorial biosynthesis were also discussed.
Key words:  Romidepsin  Histone deacetylase inhibitor  Biosynthetic gene cluster  Genomemining  Combinatorial biosynthesis
Today's Visits:487    Total Visits:2383201
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.